Outlook Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.22

-0.01 (-4.46%)

As of May 16, 2:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +15,510.4% upside

Low Target $27.07

Average Target $34.78

High Target $51.13

Current Price $0.22

Current
$0.22

Target
$34.78

$27.07 $34.78 avg $51.13

Scenario Analysis

Bear Case

$27.07

12,049.9%

Low target

Base Case

$34.78

+15,510.4%

Avg target

Bull Case

$51.13

+22,848.8%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.39

-93.4% from high

52-Week Low

$0.16

+38.3% from low

Target vs 52W High

$34.78

+926.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%